Contineum Therapeutics, Inc. (CTNM) Institutional Ownership & Insider Trading
102 institutions reported holding Contineum Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 31 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CTNMContineum Therapeutics, Inc.Follow CTNM — free
—
Price chart with a free account
- Market cap
- 312.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters102 institutions held 81.2% of the shares. Across filers that reported both quarters, shares held changed -0.1%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 102 | 31 | -0.1% | 31 | 27 | 19 | 15 |
| Mar 26 | 90 | 31 | +1.1% | 28 | 18 | 21 | 11 |
| Dec 25 | 79 | 30 | +69.3% | 29 | 28 | 5 | 11 |
| Sep 25 | 60 | 17 | +27.7% | 17 | 12 | 18 | 21 |
| Jun 25 | 69 | 14 | -9.5% | 12 | 25 | 22 | 19 |
| Mar 25 | 62 | 15 | -3.0% | 18 | 6 | 16 | 5 |
| Dec 24 | 61 | 16 | +9.9% | 26 | 10 | 7 | 3 |
| Sep 24 | 51 | 14 | +5.8% | 14 | 7 | 15 | 5 |
Contineum Therapeutics, Inc. — questions
- Who owns Contineum Therapeutics, Inc. stock?
- 102 institutions reported Contineum Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: SUVRETTA CAPITAL MANAGEMENT, LLC (7.5%), Jupiter Topco LLC (7.3%), BlackRock, Inc. (5.5%).
- Are Contineum Therapeutics, Inc. insiders buying or selling?
- 31 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Contineum Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.